235 related articles for article (PubMed ID: 19332518)
1. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer.
Clark CH; Miles EA; Urbano MT; Bhide SA; Bidmead AM; Harrington KJ; Nutting CM;
Br J Radiol; 2009 Jul; 82(979):585-94. PubMed ID: 19332518
[TBL] [Abstract][Full Text] [Related]
2. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application.
Qi XS; Ruan D; Lee SP; Pham A; Kupelian P; Low DA; Steinberg M; Demarco J
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):817-24. PubMed ID: 25752396
[TBL] [Abstract][Full Text] [Related]
3. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
Moore KL; Brame RS; Low DA; Mutic S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
[TBL] [Abstract][Full Text] [Related]
4. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.
Guerrero Urbano MT; Clark CH; Kong C; Miles E; Dearnaley DP; Harrington KJ; Nutting CM; PARSPORT Trial Management Group
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):604-13. PubMed ID: 17706404
[TBL] [Abstract][Full Text] [Related]
5. Multicentre quality assurance of intensity-modulated radiation therapy plans: a precursor to clinical trials.
Williams MJ; Bailey M; Forstner D; Metcalfe PE
Australas Radiol; 2007 Oct; 51(5):472-9. PubMed ID: 17803801
[TBL] [Abstract][Full Text] [Related]
6. Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction.
van der Laan HP; Gawryszuk A; Christianen ME; Steenbakkers RJ; Korevaar EW; Chouvalova O; Wopken K; Bijl HP; Langendijk JA
Radiother Oncol; 2013 Jun; 107(3):282-7. PubMed ID: 23742959
[TBL] [Abstract][Full Text] [Related]
7. Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapy.
Kierkels RG; Visser R; Bijl HP; Langendijk JA; van 't Veld AA; Steenbakkers RJ; Korevaar EW
Radiat Oncol; 2015 Apr; 10():87. PubMed ID: 25885444
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry audit for a multi-centre IMRT head and neck trial.
Clark CH; Hansen VN; Chantler H; Edwards C; James HV; Webster G; Miles EA; Guerrero Urbano MT; Bhide SA; Bidmead AM; Nutting CM;
Radiother Oncol; 2009 Oct; 93(1):102-8. PubMed ID: 19596158
[TBL] [Abstract][Full Text] [Related]
9. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Nutting CM; Morden JP; Harrington KJ; Urbano TG; Bhide SA; Clark C; Miles EA; Miah AB; Newbold K; Tanay M; Adab F; Jefferies SJ; Scrase C; Yap BK; A'Hern RP; Sydenham MA; Emson M; Hall E;
Lancet Oncol; 2011 Feb; 12(2):127-36. PubMed ID: 21236730
[TBL] [Abstract][Full Text] [Related]
10. Simple tool for prediction of parotid gland sparing in intensity-modulated radiation therapy.
Gensheimer MF; Hummel-Kramer SM; Cain D; Quang TS
Med Dosim; 2015; 40(3):232-4. PubMed ID: 25704638
[TBL] [Abstract][Full Text] [Related]
11. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site.
Bhide S; Clark C; Harrington K; Nutting CM
Med Dosim; 2007; 32(3):188-95. PubMed ID: 17707198
[TBL] [Abstract][Full Text] [Related]
12. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
13. Static and rotational intensity modulated techniques for head-neck cancer radiotherapy: a planning comparison.
Broggi S; Perna L; Bonsignore F; Rinaldin G; Fiorino C; Chiara A; Frigerio C; Butti I; Sangalli G; Dell'Oca I; Di Muzio N; Cattaneo GM; Declich F
Phys Med; 2014 Dec; 30(8):973-9. PubMed ID: 25113943
[TBL] [Abstract][Full Text] [Related]
14. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer.
Naismith O; Mayles H; Bidmead M; Clark CH; Gulliford S; Hassan S; Khoo V; Roberts K; South C; Hall E; Dearnaley D;
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):611-620. PubMed ID: 31201110
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy for head and neck cancer.
Caglar HB; Allen AM
Clin Adv Hematol Oncol; 2007 Jun; 5(6):425-31. PubMed ID: 17679916
[TBL] [Abstract][Full Text] [Related]
17. Multicenter collaborative quality assurance program for the province of Ontario, Canada: first-year results.
Létourneau D; McNiven A; Jaffray DA
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):164-9. PubMed ID: 23462421
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
19. Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study.
Saibishkumar EP; Jha N; Scrimger RA; MacKenzie MA; Daly H; Field C; Fallone G; Parliament MB
Radiother Oncol; 2007 Oct; 85(1):98-104. PubMed ID: 17923162
[TBL] [Abstract][Full Text] [Related]
20. Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy.
Wills L; Maggs R; Lewis G; Jones G; Nixon L; Staffurth J; Crosby T;
Radiat Oncol; 2017 Nov; 12(1):179. PubMed ID: 29141663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
